Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting pathological upstaging after radical nephroureterectomy in patients with upper tract urothelial carcinoma: results from a multicenter cohort study.
Yamaguchi R, Kagawa H, Yoshihara K, Yamamoto S, Hara S, Miyajima K, Enei Y, Fukuokaya W, Iwatani K, Imai Y, Atsuta M, Mori K, Igarashi T, Aikawa K, Yanagisawa T, Kimura S, Tashiro K, Tsuzuki S, Ishii G, Higuchi T, Sato S, Yamada Y, Furuta A, Shimomura T, Kimura T, Miki J, Urabe F. Yamaguchi R, et al. Among authors: fukuokaya w. Transl Androl Urol. 2024 Nov 30;13(11):2384-2395. doi: 10.21037/tau-24-357. Epub 2024 Nov 27. Transl Androl Urol. 2024. PMID: 39698572 Free PMC article.
Ten-Year Outcomes of a Phase 3, Multicenter, Randomized Controlled Trial (SHIP0804) With 3-Month Neoadjuvant Androgen Deprivation Prior to 125I-Seed Transperineal Prostate Brachytherapy Followed by Nil Versus 9-Month Adjuvant Hormonal Therapy in Patients With Intermediate-Risk Prostate Cancer.
Fukuokaya W, Miki K, Aoki M, Takahashi H, Saito S, Yorozu A, Kikuchi T, Dokiya T, Egawa S; SHIP Collaborative Group. Fukuokaya W, et al. Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03584-3. doi: 10.1016/j.ijrobp.2024.11.010. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39551103
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis.
Yanagisawa T, Mori K, Matsukawa A, Kawada T, Katayama S, Laukhtina E, Rajwa P, Quhal F, Pradere B, Fukuokaya W, Iwatani K, Afferi L, Marcq G, Mertens LS, Gallioli A, Tully KH, Caño-Velasco J, Subiela JD, Abu-Ghanem Y, Grobet-Jeandin E, Del Giudice F, Pichler R, Teoh JY, Moschini M, Krajewski W, Miki J, Shariat SF, Kimura T; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Yanagisawa T, et al. Among authors: fukuokaya w. Target Oncol. 2024 Nov 13. doi: 10.1007/s11523-024-01114-4. Online ahead of print. Target Oncol. 2024. PMID: 39535690
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Fujimoto S, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: fukuokaya w. Int J Clin Oncol. 2024 Oct 28. doi: 10.1007/s10147-024-02649-2. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39467994
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study.
Hara S, Urabe F, Tashiro K, Goto Y, Iwamoto Y, Ohtsuka T, Fukuokaya W, Imai Y, Iwatani K, Atsuta M, Mori K, Igarashi T, Aikawa K, Yanagisawa T, Kimura S, Murakami M, Tsuzuki S, Yanada BA, Hata K, Furuta A, Yamada H, Miki J, Kimura T; JIKEI-YAYOI Collaborative Group. Hara S, et al. Among authors: fukuokaya w. Jpn J Clin Oncol. 2024 Oct 19:hyae146. doi: 10.1093/jjco/hyae146. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39426804
Clinical significance of PSA dynamics in castration-sensitive prostate cancer treated with ARSI doublet therapy: A multicenter study.
Urabe F, Hatakeyama S, Yanagisawa T, Narita S, Muramoto K, Katsumi K, Takahashi H, Fukuokaya W, Mori K, Tashiro K, Iwatani K, Shimomura T, Miki J, Habuchi T, Kimura T; JHA Collaborative Group. Urabe F, et al. Among authors: fukuokaya w. Urol Oncol. 2024 Oct 9:S1078-1439(24)00670-7. doi: 10.1016/j.urolonc.2024.09.028. Online ahead of print. Urol Oncol. 2024. PMID: 39389903
Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.
Kato M, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Yamamoto S, Matsue T, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Uchida J; Japan Urological Oncology Group. Kato M, et al. Among authors: fukuokaya w. Int J Clin Oncol. 2024 Dec;29(12):1937-1945. doi: 10.1007/s10147-024-02636-7. Epub 2024 Oct 9. Int J Clin Oncol. 2024. PMID: 39379757
Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor.
Yamamoto Y, Fujimoto S, Hashimoto M, Minami T, Fukuokaya W, Yanagisawa T, Saruta M, Takahara K, Nishimura K, Tsujino T, Nakamori Y, Hashimoto T, Kimura T, Shiroki R, Azuma H, Ohno Y, Fujita K. Yamamoto Y, et al. Among authors: fukuokaya w. Int J Clin Oncol. 2024 Dec;29(12):1946-1958. doi: 10.1007/s10147-024-02637-6. Epub 2024 Oct 1. Int J Clin Oncol. 2024. PMID: 39352622
Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer.
Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T. Fukuokaya W, et al. Int J Urol. 2024 Dec;31(12):1414-1422. doi: 10.1111/iju.15585. Epub 2024 Sep 18. Int J Urol. 2024. PMID: 39291802
83 results